Metabolomic assessment of mechanisms underlying anti-renal fibrosis properties of petroleum ether extract from Amygdalus mongolica

Metabolomic assessment of mechanisms underlying anti-renal fibrosis properties of petroleum ether extract from Amygdalus mongolica

Context The petroleum ether extract (PET) of Amygdalus mongolica (Maxim.) Ricker (Rosaceae) has an ameliorative effect on renal fibrosis (RF). Objective To evaluate the antifibrotic effects of A. mongolica seeds PET on RF by serum metabolomics, biochemical and histopathological analyses. Materials a...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Chen Gao, Wan-fu Bai, Hong-bing Zhou, Hai-mei Hao, Ying-chun Bai, Quan-li Liu, Hong Chang, Song-li Shi
Format:	Artykuł
Język:	English
Wydane:	Taylor & Francis Group 2021-01-01
Seria:	Pharmaceutical Biology
Hasła przedmiotowe:	traditional chinese medicine renal fibrosis biomarkers metabolic pathway mechanism research
Dostęp online:	http://dx.doi.org/10.1080/13880209.2021.1920619

Podobne zapisy

Metabolomics reveal the mechanism for anti-renal fibrosis effects of an n-butanol extract from Amygdalus mongolica
od: Gao Chen, i wsp.
Wydane: (2022-09-01)

Study on the mechanism of Amygdalus mongolica oil anti-renal fibrosis based on metabolomics and transcriptomics
od: Haimei Hao, i wsp.
Wydane: (2022-12-01)

Study on miRNA expression and regulatory network of Amygdalus mongolica oil and amygdalin in the treatment of pulmonary fibrosis
od: Jiaxing Gao, i wsp.
Wydane: (2024-06-01)

Amygdalin isolated from Amygdalus mongolica protects against hepatic fibrosis in rats
od: Wang Jia, i wsp.
Wydane: (2021-09-01)

Metabolomics reveals the renoprotective effect of n-butanol extract and amygdalin extract from Amygdalus mongolica in rats with renal fibrosis
od: Wanfu Bai, i wsp.
Wydane: (2021-01-01)

The intervention effect of Amygdalus mongolica oil on the metabolomics and intestinal flora in pulmonary fibrosis
od: Qian Li, i wsp.
Wydane: (2022-11-01)

Effects of N-butanol extract of Amygdalus mongolica on rats with bleomycin‐induced pulmonary fibrosis based on metabolomics
od: Chen Gao, i wsp.
Wydane: (2023-11-01)

Assessment of the renal function and fibrosis indexes of conventional western medicine with Chinese medicine for dredging collaterals on treating renal fibrosis: A systematic review and meta-analysis
od: Guo Yingbo, i wsp.
Wydane: (2024-07-01)

Advances in the study of key cells and signaling pathways in renal fibrosis and the interventional role of Chinese medicines
od: Lijuan Liang, i wsp.
Wydane: (2024-12-01)

Natural products: potential drugs for the treatment of renal fibrosis
od: Zijun Zhou, i wsp.
Wydane: (2022-08-01)

Fu-Fang-Jin-Qian-Cao herbal granules protect against the calcium oxalate-induced renal EMT by inhibiting the TGF-β/smad pathway
od: Wen-Rui Liu, i wsp.
Wydane: (2020-01-01)

Impact of baicalin and components of Scutellaria baicalensis on renal fibrosis of diabetic kidney disease
od: Jiarui Li, i wsp.
Wydane: (2024-12-01)

Metabolic reprogramming and renal fibrosis: what role might Chinese medicine play?
od: Weili Wang, i wsp.
Wydane: (2024-10-01)

Yiqi Juanshen decoction alleviates renal interstitial fibrosis by targeting the LOXL2/PI3K/AKT pathway to suppress EMT and inflammation
od: Kaiyue Tan, i wsp.
Wydane: (2025-02-01)

Stem cells in the treatment of renal fibrosis: a review of preclinical and clinical studies of renal fibrosis pathogenesis
od: Yiping Liu, i wsp.
Wydane: (2021-06-01)

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
od: Shan-Shan Li, i wsp.
Wydane: (2021-08-01)

Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
od: Zhong Yanan, i wsp.
Wydane: (2023-06-01)

Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
od: Ling Nie, i wsp.
Wydane: (2020-03-01)

Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
od: Shanshan Zhou, i wsp.
Wydane: (2020-04-01)

Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway
od: Hongbo Li, i wsp.
Wydane: (2018-08-01)

Tongluo Yishen Decoction Ameliorates Renal Fibrosis via NLRP3-Mediated Pyroptosis In Vivo and In Vitro
od: Qi Jia, i wsp.
Wydane: (2022-07-01)

Drugs for treating myocardial fibrosis
od: Zhanhong Ren, i wsp.
Wydane: (2023-09-01)

Multi-target regulatory effects of rhaponticin in a rat model of hepatic fibrosis revealed by non-targeted metabolomics
od: Min Yang, i wsp.
Wydane: (2025-01-01)

A metabolomic approach to elucidate the inhibitory effects of baicalin in pulmonary fibrosis
od: Hong Chang, i wsp.
Wydane: (2021-01-01)

Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis
od: Jun Li, i wsp.
Wydane: (2022-01-01)

Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products
od: Wei Tan, i wsp.
Wydane: (2022-07-01)

Signaling Pathways Involved in Diabetic Renal Fibrosis
od: Yuqing Zhang, i wsp.
Wydane: (2021-07-01)

Autophagy in renal fibrosis: Protection or promotion?
od: Rong Dai, i wsp.
Wydane: (2022-08-01)

Cell–Matrix Interactions in Renal Fibrosis
od: Kristin P. Kim, i wsp.
Wydane: (2022-12-01)

The role of lncRNA and miRNA in the pathogenesis of renal fibrosis
od: Liang CHANG, i wsp.
Wydane: (2023-04-01)

Phylogeography of Amygdalus mongolica in relation to Quaternary climatic aridification and oscillations in northwestern China
od: Lin Zhang, i wsp.
Wydane: (2022-04-01)

Total Flavonoids from Leaves of Carya Cathayensis Ameliorate Renal Fibrosis via the miR-21/Smad7 Signaling Pathway
od: Xiaoli Wu, i wsp.
Wydane: (2018-09-01)

Dissecting Efficacy and Metabolic Characteristic Mechanism of Taxifolin on Renal Fibrosis by Multivariate Approach and Ultra-Performance Liquid Chromatography Coupled With Mass Spectrometry-Based Metabolomics Strategy
od: Lei Ren, i wsp.
Wydane: (2021-01-01)

Dapagliflozin inhibits ferroptosis and ameliorates renal fibrosis in diabetic C57BL/6J mice
od: Zhen Zhang, i wsp.
Wydane: (2025-02-01)

Naringin ameliorates experimental diabetic renal fibrosis by inhibiting the ERK1/2 and JNK MAPK signaling pathways
od: Yan Yang, i wsp.
Wydane: (2018-11-01)

Research status and hotspots of traditional Chinese medicine in treatment of pulmonary fibrosis: based on bibliometric analysis
od: MIN Yi
Wydane: (2023-10-01)

Renal Fibrosis Is Significantly Attenuated Following Targeted Disruption of Cd40 in Experimental Renal Ischemia
od: Shungang Zhang, i wsp.
Wydane: (2020-04-01)

The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway
od: Yadong Fu, i wsp.
Wydane: (2021-09-01)

Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis
od: Xiaohui Meng, i wsp.
Wydane: (2025-01-01)

Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy
od: Shengju Wang, i wsp.
Wydane: (2023-07-01)